6A3A.SG Autolus Therapeutics Ltd. (ADRs | US05280R1005
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | - | 316.710.525,57 | 407.199.219,97 | 348.645.233,18 |
| Enterprise Value | - | 265.741.525,57 | 374.454.219,97 | 328.356.233,18 |
| Trailing P/E | - | - | - | - |
| Forward P/E | - | - | - | - |
| Price to Sales | - | 3,42 | 5,4 | 6,82 |
| Price to Book | - | 2,91 | 2,29 | 1,31 |
| EV/Revenue | - | 2,87 | 4,97 | 6,43 |
| EV/EBITDA | - | - | - | - |